Related Experiment Video

Updated: Jun 27, 2026

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings
06:39

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings

Published on: June 13, 2025

Safety of frequent venous blood sampling in a pediatric research population

Sarabeth Broder-Fingert1, William F Crowley, Paul A Boepple

  • 1Harvard Reproductive Sciences Center and Reproductive Endocrine Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA. sbroder-finger@partners.org

The Journal of Pediatrics
|November 26, 2008
PubMed

Insights

Frequent blood draws in children with central precocious puberty are safe when hematological indices are monitored. This study found no significant long-term effects on hemoglobin or ferritin levels.

Area of Science:

  • Pediatric Endocrinology
  • Hematology
  • Clinical Research

Background:

  • Central precocious puberty (CPP) requires monitoring, often involving frequent blood sampling.
  • Longitudinal studies necessitate understanding the impact of repeated phlebotomy on pediatric hematological parameters.

Purpose of the Study:

  • To assess hematological indices in healthy children with CPP undergoing frequent venous sampling.
  • To evaluate the safety and impact of repeated blood collection during and after gonadotropin-releasing hormone analogue treatment.

Main Methods:

  • Thirty-four female subjects with CPP underwent frequent venous sampling (every 10-20 min for 8-16 hours) every 6 months for ≥3 years.
  • Hemoglobin (Hgb), mean corpuscular volume, and ferritin levels were measured before and after phlebotomy sessions.
  • Safety guidelines included monitoring hematological indices and limiting phlebotomy volume (<10 mL/kg/24 hours).

Main Results:

  • Initial Hgb levels dropped slightly post-sampling but recovered within 3 months and remained within age-appropriate ranges.
  • No significant longitudinal differences in Hgb, mean corpuscular volume, or ferritin were observed over 3 years.
  • No clinically significant adverse effects related to phlebotomy were reported.

Conclusions:

  • Frequent venous sampling in pediatric populations is safe when established safety guidelines are followed.
  • Monitoring hematological indices, controlling phlebotomy volume, and considering iron replacement are crucial for safety.
  • This study supports the feasibility of intensive blood sampling in pediatric research.
Abstract

More Related Videos

Subclavian Vein Blood Sampling in Conscious Rats03:52

Subclavian Vein Blood Sampling in Conscious Rats

Published on: November 3, 2023

Repetitive Blood Sampling from the Subclavian Vein of Conscious Rat04:52

Repetitive Blood Sampling from the Subclavian Vein of Conscious Rat

Published on: February 9, 2022

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Blood Studies I: ABG and VBG01:26

Blood Studies I: ABG and VBG

Blood studies are critical in the medical field, enabling healthcare professionals to assess a patient's health status accurately. This page will focus on two significant blood studies: Arterial Blood Gas (ABG) and Venous Blood Gas (VBG).
Arterial Blood Gas (ABG)
Arterial Blood Gas (ABG) studies are crucial for assessing the lungs' ability to supply oxygen and remove carbon dioxide, reflecting the patient's ventilation status. They also help understand the kidneys' capacity to reabsorb or...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...